BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mirzaei S, Saghari S, Bassiri F, Raesi R, Zarrabi A, Hushmandi K, Sethi G, Tergaonkar V. NF-κB as a regulator of cancer metastasis and therapy response: A focus on epithelial-mesenchymal transition. J Cell Physiol 2022. [PMID: 35561232 DOI: 10.1002/jcp.30759] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang MH, Ha IJ, Ahn J, Kim CK, Lee M, Ahn KS. Potential function of loliolide as a novel blocker of epithelial-mesenchymal transition in colorectal and breast cancer cells. Cell Signal 2023;105:110610. [PMID: 36707041 DOI: 10.1016/j.cellsig.2023.110610] [Reference Citation Analysis]
2 Kim NY, Ha IJ, Um JY, Kumar AP, Sethi G, Ahn KS. Loganic acid regulates the transition between epithelial and mesenchymal-like phenotypes by alleviating MnSOD expression in hepatocellular carcinoma cells. Life Sci 2023;317:121458. [PMID: 36731649 DOI: 10.1016/j.lfs.2023.121458] [Reference Citation Analysis]
3 Sethi G, Rath P, Chauhan A, Ranjan A, Choudhary R, Ramniwas S, Sak K, Aggarwal D, Rani I, Tuli HS. Apoptotic Mechanisms of Quercetin in Liver Cancer: Recent Trends and Advancements. Pharmaceutics 2023;15. [PMID: 36840034 DOI: 10.3390/pharmaceutics15020712] [Reference Citation Analysis]
4 Bala N, Yu L, Liu LP, Shelton L, Xu Y, Ghayee HK, Alli AA. Metabolic Characterization and Glyceraldehyde-3-Phosphate Dehydrogenase-Dependent Regulation of Epithelial Sodium Channels in hPheo1 Wild-type and SDHB Knockdown Cells. Endocrinology 2023;164:bqad026. [PMID: 36763043 DOI: 10.1210/endocr/bqad026] [Reference Citation Analysis]
5 Cippitelli M, Stabile H, Kosta A, Petillo S, Lucantonio L, Gismondi A, Santoni A, Fionda C. Role of NF-κB Signaling in the Interplay between Multiple Myeloma and Mesenchymal Stromal Cells. Int J Mol Sci 2023;24. [PMID: 36768145 DOI: 10.3390/ijms24031823] [Reference Citation Analysis]
6 Paskeh MDA, Ghadyani F, Hashemi M, Abbaspour A, Zabolian A, Javanshir S, Razzazan M, Mirzaei S, Entezari M, Goharrizi MASB, Salimimoghadam S, Aref AR, Kalbasi A, Rajabi R, Rashidi M, Taheriazam A, Sethi G. Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges. Pharmacol Res 2023;187:106553. [PMID: 36400343 DOI: 10.1016/j.phrs.2022.106553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tuli HS, Kaur J, Vashishth K, Sak K, Sharma U, Choudhary R, Behl T, Singh T, Sharma S, Saini AK, Dhama K, Varol M, Sethi G. Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosis. Arch Toxicol 2023;97:103-20. [PMID: 36443493 DOI: 10.1007/s00204-022-03421-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Carvalho de Oliveira J, Mathias C, Oliveira VC, Pezuk JA, Brassesco MS. The Double Face of miR-708: A Pan-Cancer Player with Dissociative Identity Disorder. Genes (Basel) 2022;13. [PMID: 36553642 DOI: 10.3390/genes13122375] [Reference Citation Analysis]
9 Zhang J, Jung YY, Mohan CD, Deivasigamani A, Chinnathambi A, Alharbi SA, Rangappa KS, Hui KM, Sethi G, Ahn KS. Nimbolide enhances the antitumor effect of docetaxel via abrogation of the NF-κB signaling pathway in prostate cancer preclinical models. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2022;1869:119344. [DOI: 10.1016/j.bbamcr.2022.119344] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Wang Y, Ma H, Narula A, Liu L, Ahn KS. Molecular targets and anticancer potential of evodiamine. Phytochemistry Letters 2022;52:92-103. [DOI: 10.1016/j.phytol.2022.10.001] [Reference Citation Analysis]
11 Guan C, Zhou X, Li H, Ma X, Zhuang J. NF-κB inhibitors gifted by nature: The anticancer promise of polyphenol compounds. Biomedicine & Pharmacotherapy 2022;156:113951. [DOI: 10.1016/j.biopha.2022.113951] [Reference Citation Analysis]
12 Hashemi M, Hajimazdarany S, Mohan CD, Mohammadi M, Rezaei S, Olyaee Y, Goldoost Y, Ghorbani A, Mirmazloomi SR, Gholinia N, Kakavand A, Salimimoghadam S, Ertas YN, Rangappa KS, Taheriazam A, Entezari M. Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106535] [Reference Citation Analysis]
13 Jayaprakash S, Hegde M, BharathwajChetty B, Girisa S, Alqahtani MS, Abbas M, Sethi G, Kunnumakkara AB. Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer. Int J Mol Sci 2022;23:12380. [PMID: 36293239 DOI: 10.3390/ijms232012380] [Reference Citation Analysis]
14 Yang MH, Mohan CD, Deivasigamani A, Chinnathambi A, Alharbi SA, Rangappa KS, Jung SH, Ko H, Hui KM, Sethi G, Ahn KS. Procaine Abrogates the Epithelial-Mesenchymal Transition Process through Modulating c-Met Phosphorylation in Hepatocellular Carcinoma. Cancers 2022;14:4978. [DOI: 10.3390/cancers14204978] [Reference Citation Analysis]
15 Vasileva NS, Kuligina EV, Dymova MA, Savinovskaya YI, Zinchenko ND, Ageenko AB, Mishinov SV, Dome AS, Stepanov GA, Richter VA, Semenov DV. Transcriptome Changes in Glioma Cells Cultivated under Conditions of Neurosphere Formation. Cells 2022;11:3106. [PMID: 36231068 DOI: 10.3390/cells11193106] [Reference Citation Analysis]
16 Hashemi M, Mirzaei S, Barati M, Hejazi ES, Kakavand A, Entezari M, Salimimoghadam S, Kalbasi A, Rashidi M, Taheriazam A, Sethi G. Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects. Life Sci 2022;309:120984. [PMID: 36150461 DOI: 10.1016/j.lfs.2022.120984] [Reference Citation Analysis]
17 Kou Y, Zhu R, Sun Q, Li Z, Feng X, Xu H. Connexin 43 upregulation by dioscin‐inhibited gastric cancer metastasis by suppressing PI3K /Akt pathway. Food Science & Nutrition. [DOI: 10.1002/fsn3.3006] [Reference Citation Analysis]
18 Hirano T, Arai E, Fujimoto M, Nakayama Y, Tian Y, Ito N, Makabe T, Yamagami W, Susumu N, Aoki D, Kanai Y. Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles. J Gynecol Oncol 2022. [PMID: 36047377 DOI: 10.3802/jgo.2022.33.e74] [Reference Citation Analysis]
19 Kim NY, Jung YY, Yang MH, Um J, Sethi G, Ahn KS. Isoimperatorin down-regulates epithelial mesenchymal transition through modulating NF-κB signaling and CXCR4 expression in colorectal and hepatocellular carcinoma cells. Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110433] [Reference Citation Analysis]